FY25 revenue consensus $86.89M. The raised revenue guidance represents a growth of approximately 33%-36% over the company’s prior year revenue.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CBLL:
- Ceribell reports Q3 EPS (37c), consensus (41c)
- Ceribell files $300M mixed securities shelf
- Ceribell, Inc.: Strong Buy Rating Amid Market Potential and Clinical Advancements
- Ceribell’s Delirium Study: A New Frontier in EEG Technology
- Ceribell, Inc.: Innovative EEG System and Market Potential Drive Buy Rating